IL17A and neoplasm: Expression of IL-17 and IL-17-induced inflammatory molecules has been significantly upregulated during progression from normal mucosa to hyperplasia and tumor formation, while inhibition of IL-17 delayed the development of precancerous and cancerous lesions in mice treated with 4-Nitroquinoline 1-oxide (4NQO), and prolonged their survival [93].